Biologics/Immunotherapy News

A new immunotherapy company, Celimmune LLC, plans to focus on clinical development of novel treatments for celiac and other autoimmune diseases, according to a press release.

HOUSTON — A varicella zoster virus vaccination program resulted in increased asthma morbidity and an increase in mortality when there was delayed onset of asthma after varicella zoster virus, according to an abstract presented at the American Academy of Allergy, Asthma and Immunology Annual Meeting.

HOUSTON ─ Three injections of intralymphatic immunotherapy appeared safe for the treatment of teenagers with grass pollen-induced rhinoconjunctivitis, according to late-breaking data presented at the American Academy of Allergy, Asthma and Immunology Annual Meeting.

Healio.com will present live coverage of the American Academy of Allergy, Asthma and Immunology annual meeting today through Feb. 24 in Houston.

Immunoglobulin G4 antibodies prohibited major peanut allergen reactions in patients sensitized but tolerant to peanuts, according to study results.

Individuals with peanut allergy experienced moderate levels of desensitization after 3 years of sublingual immunotherapy, according to study results.

Using omega-3 supplements had no benefit during a 3-week treatment period for participants with asthma, according to new study results.

Researchers in the United Kingdom, the United States and Australia have discovered a mechanism in which immune cells in the skin act as a barrier to infection, according to study results.

Emotions such as joy, awe and pride may lead to increases in anti-inflammatory cytokines, according to recent study results.

A sublingual immunotherapy was more cost effective when compared with subcutaneous immunotherapy in treating patients for grass pollen allergic rhinoconjunctivitis, according to recent study results.